Ultragenyx Announces Upcoming Setrusumab Presentations at the ASBMR 2024 Annual Meeting
RARE Stock | USD 47.72 0.00 0.00% |
About 76 percent of Ultragenyx's shareholders are selling. The analysis of the overall investor sentiment regarding Ultragenyx suggests that quite a large number of traders are terrified. The current market sentiment, together with Ultragenyx's historical and current headlines, can help investors time the market. In addition, many technical investors use Ultragenyx stock news signals to limit their universe of possible portfolio assets.
Ultragenyx |
NOVATO, Calif., Sept. 26, 2024 -- Ultragenyx Pharmaceutical Inc. today announced that it will present seven abstracts related to its ongoing late-stage program evaluating setrusumab and osteogenesis imperfecta , including a late-breaker oral presentation of the 14-month data from the Phase 23 Orbit study, at the American Society for Bone and Mineral Research 2024 Annual Meeting. The meeting is being held September 27-30, 2024, in Toronto, Cana
Read at finance.yahoo.com
Ultragenyx Current Investor Sentiment
Panic Vs Confidence
24
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Ultragenyx's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Ultragenyx.
News SentimentBearish | Hype SentimentBearish | Insider SentimentDisposing |
Ultragenyx Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Ultragenyx can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Ultragenyx Historical Investor Sentiment
Investor biases related to Ultragenyx's public news can be used to forecast risks associated with an investment in Ultragenyx. The trend in average sentiment can be used to explain how an investor holding Ultragenyx can time the market purely based on public headlines and social activities around Ultragenyx. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ultragenyx's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ultragenyx and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Ultragenyx news discussions. The higher the estimate score, the more favorable the investor's outlook on Ultragenyx.
Ultragenyx Fundamental Analysis
We analyze Ultragenyx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ultragenyx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ultragenyx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Ultragenyx is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Ultragenyx Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ultragenyx stock to make a market-neutral strategy. Peer analysis of Ultragenyx could also be used in its relative valuation, which is a method of valuing Ultragenyx by comparing valuation metrics with similar companies.
Peers
Ultragenyx Related Equities
XFOR | X4 Pharmaceuticals | 11.43 | ||||
TERN | Terns Pharmaceuticals | 7.82 | ||||
ARVN | Arvinas | 6.13 | ||||
APLS | Apellis Pharmaceuticals | 4.63 | ||||
KURA | Kura Oncology | 3.91 | ||||
ABOS | Acumen Pharmaceuticals | 2.73 | ||||
INZY | Inozyme Pharma | 2.64 | ||||
PDSB | PDS Biotechnology | 1.90 | ||||
CRNX | Crinetics Pharmaceuticals | 1.59 | ||||
DAWN | Day One | 1.33 | ||||
INCY | Incyte | 0.87 | ||||
UTHR | United Therapeutics | 0.30 | ||||
ALNY | Alnylam Pharmaceuticals | 0.15 | ||||
AMLX | Amylyx Pharmaceuticals | 0.00 | ||||
RVMD | Revolution Medicines | 0.09 |
Complementary Tools for Ultragenyx Stock analysis
When running Ultragenyx's price analysis, check to measure Ultragenyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultragenyx is operating at the current time. Most of Ultragenyx's value examination focuses on studying past and present price action to predict the probability of Ultragenyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultragenyx's price. Additionally, you may evaluate how the addition of Ultragenyx to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |